Dodge & Cox’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66B Sell
67,397,025
-1,547,075
-2% -$35.8M 0.87% 46
2026
Q1
$1.65B Sell
68,944,100
-10,140,205
-13% -$248M 0.91% 42
2025
Q4
$1.79B Sell
79,084,305
-3,675,532
-4% -$80M 0.97% 42
2025
Q3
$1.67B Sell
82,759,837
-135,395
-0.2% -$2.27M 0.9% 43
2025
Q2
$1.18B Sell
82,895,232
-25,350
-0% -$296K 0.67% 50
2025
Q1
$871M Sell
82,920,582
-260,084
-0.3% -$2.94M 0.5% 66
2024
Q4
$1.01B Sell
83,180,666
-134,884
-0.2% -$1.76M 0.59% 59
2024
Q3
$1.22B Sell
83,315,550
-267,600
-0.3% -$3.73M 0.69% 51
2024
Q2
$1.21B Sell
83,583,150
-265,700
-0.3% -$4.25M 0.72% 51
2024
Q1
$1.37B Sell
83,848,850
-132,050
-0.2% -$2.06M 0.79% 47
2023
Q4
$1.25B Sell
83,980,900
-222,400
-0.3% -$2.52M 0.79% 50
2023
Q3
$946M Sell
84,203,300
-418,050
-0.5% -$4.85M 0.64% 55
2023
Q2
$851M Sell
84,621,350
-152,725
-0.2% -$1.42M 0.57% 62
2023
Q1
$797M Sell
84,774,075
-1,000
-0% -$11.8K 0.54% 61
2022
Q4
$1.04B Buy
84,775,075
+31,773,735
+60% +$396M 0.71% 53
2022
Q3
$658M Buy
53,001,340
+3,795,150
+8% +$66.3M 0.5% 65
2022
Q2
$966M Buy
49,206,190
+20,618,487
+72% +$488M 0.67% 54
2022
Q1
$746M Buy
28,587,703
+6,369,403
+29% +$170M 0.45% 67
2021
Q4
$631M Buy
22,218,300
+18,579,176
+511% +$578M 0.39% 64
2021
Q3
$116M Buy
+3,639,124
New +$122M 0.08% 84
2018
Q4
Sell
-2,012,033
Closed -$70.2M 182
2018
Q3
$70.2M Buy
+2,012,033
New +$70.8M 0.05% 83

Other funds holding ELAN

Dodge & Cox's ELAN Position: Q2 2026 in Review

Dodge & Cox reduced its Elanco Animal Health (ELAN) stake by 2.2% in Q2 2026, selling an estimated $35.8M and leaving 67,397,025 shares worth $1.66B. The position accounts for 0.87% of the portfolio, ranked #46.

Dodge & Cox first reported a position in ELAN in Q3 2018 and has held it in 21 quarters since. The position peaked at $1.79B in Q4 2025. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Dodge & Cox held 67,397,025 shares of Elanco Animal Health worth $1.66B as of Q2 2026.
  • Dodge & Cox sold 1,547,075 Elanco Animal Health shares in Q2 2026, an estimated $35.8M.
  • Elanco Animal Health made up 0.87% of Dodge & Cox's portfolio in Q2 2026, its #46 holding.
  • Dodge & Cox first reported a position in Elanco Animal Health in Q3 2018 and has held it in 21 quarters since.
  • Dodge & Cox's Elanco Animal Health position peaked at $1.79B in Q4 2025.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Dodge & Cox's 13F filing for Q2 2026, filed 13 Aug 2026.